当前位置:网站首页>In cooperation with the research team of the clinical trial center of the University of Hong Kong and Hong Kong Gangyi hospital, Kexing launched the clinical trial of Omicron specific inactivated vacc
In cooperation with the research team of the clinical trial center of the University of Hong Kong and Hong Kong Gangyi hospital, Kexing launched the clinical trial of Omicron specific inactivated vacc
2022-07-07 04:14:00 【sinat_ forty-one million six hundred and ninety-eight thousand 】
In recent days, , Hong Kong Gangyi Hospital ( abbreviation “Gleneagles” or “GHK”) Hold the launching ceremony of clinical trials , Kexing holding Biotechnology Co., Ltd (SINOVAC) Omicron specific inactivated novel coronavirus vaccine is used as a booster in healthy adults to enhance the safety and immunogenicity of vaccination , To provide scientific basis for formulating future vaccination strategies . This clinical trial was conducted by the clinical trial center of the University of Hong Kong (HKU-CTC) Led by the medical research team of , And cooperate with Gangyi Hospital .
This clinical trial plans to recruit 300 name 18 Healthy adult volunteers aged and over , Volunteers are required to have been vaccinated 2 Agent or 3 Agent inactivation or mRNA COVID-19 vaccine .
Assistant dean of the Li Ka Shing School of medicine, the University of Hong Kong ( recruit students )、 Clinical professor and director of infectious diseases department, Department of internal medicine, School of clinical medicine 、 Li Rujian, Professor of Huang Ruirong foundation ( Health Science pedagogy ) Professor Kong Fanyi said at the launching ceremony :“ as everyone knows , Vaccines are one of the most effective ways to deal with infectious diseases . at present , The variant of Omicron virus continues to ravage the world . It is hoped that this clinical trial can strengthen and effectively promote vaccine research and vaccination management .”
Dr. Zeng Qinglian said :“ As one of the research bases of the University of Hong Kong , We are very happy to participate in this clinical trial project , Contribute to the continuous research and development of vaccines and immunization strategies , Protect public health .”
Ms. luowenhui, director of business development of Kexing international, said :“ This time with Professor Kong 、 It is of great significance that the clinical trial center of HKU and Gangyi hospital cooperate to carry out the clinical trial of Omicron covid-19 inactivated vaccine enhancer . We hope to find solutions for Hong Kong and the world to fight against new virus variants through this test .”
Kexingyu 2021 year 12 Samples of Omicron mutants were obtained at the beginning of this month , Then actively promote novel coronavirus inactivated vaccine ( Omicron specific strain ) The development of . Preclinical studies based on animal models have shown , The vaccine is safe and effective . The clinical trial of strengthening immunity of Omicron strain was followed in 2022 year 4 month 12 Received the ethics review committee of the University of Hong Kong and Hong Kong Yi Hospital (IRB) approval , And in 4 month 14 It was approved by the Hong Kong pharmacy and poisons authority on the th , It is allowed to carry out enhanced immune clinical research on Omicron covid-19 in Hong Kong .
About Kexing holding Biotechnology Co., Ltd
Kexing biotechnology Holding Co., Ltd (SINOVAC) Is a leading biopharmaceutical company headquartered in China , Focus on the research of human infectious disease vaccine 、 innovation 、 Production and commercialization . The product portfolio of Kexing includes COVID-19 、H5N1 The flu ( Bird flu )、H1N1 The flu ( Swine flu ) And enteroviruses 71 (EV71) And other emerging infectious diseases , And for viral hepatitis 、 Seasonal flu 、 Pneumococcal pneumonia 、 Polio 、 Vaccines for other common infectious diseases such as chickenpox and mumps . The company is also constantly exploring opportunities in the international market , It is exporting vaccines to dozens of countries and international organizations .
About the clinical trial center of the University of Hong Kong
Clinical trial center of the University of Hong Kong (HKU-CTC) It is a one-stop clinical research management platform , It is committed to promoting the medical school of the University of Hong Kong to carry out clinical research projects in a professional manner . Since its establishment , The clinical trial center of the University of Hong Kong cooperates with global sponsors and research doctors , More than 1000 clinical studies initiated by the industry or researchers have been carried out .
About Hong Kong Gangyi Hospital
Hong Kong Gangyi hospital is a private hospital with multiple specialties , Located in Wong Chuk Hang, Southern District of Hong Kong Island , Equipped with 500 Beds , Provide advanced medical technology and comprehensive clinical services , Cover more than 35 There are specialties and branches . As the top private teaching hospital in Hong Kong , Gangyi hospital has made contributions to the training of medical professionals and the progress of clinical research . Gangyi hospital by IHH Medical group and Xinchuang Group Co., Ltd. jointly invest , The University of Hong Kong is the exclusive clinical partner .
[ Right up ] Assistant dean of the Li Ka Shing School of medicine, the University of Hong Kong ( recruit students )、 Clinical professor and director of infectious diseases department, Department of internal medicine, School of clinical medicine 、 Li Rujian, Professor of Huang Ruirong foundation ( Health Science pedagogy ) Professor Kong Fanyi ; Dr. Zeng Qinglian, CEO of Hong Kong joy Hospital ; Ms. Luo Wenhui, director of international business development of Kexing Asia Pacific ; Mr. You Guangzhi, managing director of the clinical trial center of the University of Hong Kong .( Photo : American business information )
边栏推荐
- 【OA】Excel 文档生成器: Openpyxl 模块
- Adaptive non European advertising retrieval system amcad
- 二进制、八进制、十六进制
- 如何检测mysql代码运行是否出现死锁+binlog查看
- ERROR: Could not build wheels for pycocotools which use PEP 517 and cannot be installed directly
- termux设置电脑连接手机。(敲打命令贼快),手机termux端口8022
- Ggplot facet detail adjustment summary
- 使用 Dumpling 备份 TiDB 集群数据到 GCS
- Use facet to record operation log
- 2022中青杯数学建模B题开放三孩背景下的生育政策研究思路
猜你喜欢
Analysis on urban transportation ideas of 2022 Zhongqing cup C
Food Chem|深度学习根据成分声明准确预测食品类别和营养成分
Web service performance monitoring scheme
运算放大器应用汇总1
接口自动化测试实践指导(中):接口测试场景有哪些
2022年电工杯B 题 5G 网络环境下应急物资配送问题思路分析
一些常用软件相关
硬件开发笔记(十): 硬件开发基本流程,制作一个USB转RS232的模块(九):创建CH340G/MAX232封装库sop-16并关联原理图元器件
Create commonly used shortcut icons at the top of the ad interface (menu bar)
Mongo shell, the most complete mongodb in history
随机推荐
[development software] tilipa Developer Software
【编码字体系列】OpenDyslexic字体
ABAP 动态内表分组循环
idea gradle lombok 报错集锦
List interview common questions
【ArcGIS教程】专题图制作-人口密度分布图——人口密度分析
UltraEdit-32 温馨提示:右协会,取消 bak文件[通俗易懂]
超越Postman,新一代国产调试工具Apifox,用起来够优雅
2022 electrician cup question B analysis of emergency materials distribution under 5g network environment
CUDA Programming
2022 electrician cup a question high proportion wind power system energy storage operation and configuration analysis ideas
ABAP dynamic inner table grouping cycle
硬件开发笔记(十): 硬件开发基本流程,制作一个USB转RS232的模块(九):创建CH340G/MAX232封装库sop-16并关联原理图元器件
Redis源码学习(31),字典学习,dict.c(一)
[OA] excel document generator: openpyxl module
cuda编程
机器人(自动化)课程的持续学习-2022-
Learn how to use js to merge two objects into one object assign()
使用 BR 备份 TiDB 集群到 GCS
你心目中的数据分析 Top 1 选 Pandas 还是选 SQL?